Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction.

Name: Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction.
Author: Zhu, Mojun

Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction. — المؤلف: Zhu, Mojun — Clinical cancer research : an official journal of the American Association for Cancer Research 20220718

المؤلف: Zhu, Mojun
النشر: Clinical cancer research : an official journal of the American Association for Cancer Research 20220718
الوصف: 3021-3031 p.
الموضوعات: Adenocarcinoma؛ Antibodies, Monoclonal, Humanized؛ Antineoplastic Agents, Immunological؛ B7-H1 Antigen؛ Esophageal Neoplasms؛ Esophagogastric Junction؛ Humans؛ Neoadjuvant Therapy